Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 57,326 | -24,285 | -50,053 | -93,639 | 216,312 |
| Depreciation Amortization | 147,406 | 107,247 | 67,146 | 1,309 | 86,681 |
| Income taxes - deferred | -49,254 | -36,246 | -18,598 | -4,378 | -10,097 |
| Accounts receivable | -55,041 | -50,690 | -21,889 | -16,014 | -48,846 |
| Accounts payable and accrued liabilities | -37,966 | -33,865 | -31,555 | 8,579 | 5,089 |
| Other Working Capital | -60,509 | -60,689 | -61,538 | -11,494 | -80,958 |
| Other Operating Activity | 405,644 | 371,872 | 260,134 | 184,360 | 120,250 |
| Operating Cash Flow | $407,606 | $273,344 | $143,647 | $68,723 | $288,431 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36,347 | -22,799 | -14,660 | -3,527 | -9,976 |
| Net Acquisitions | -828,676 | -828,676 | -828,676 | -828,676 | N/A |
| Purchase Sale Intangibles | -202,626 | -202,000 | -127,000 | -125,000 | -6,288 |
| Other Investing Activity | -202,626 | -202,000 | -127,000 | -125,000 | -6,288 |
| Investing Cash Flow | $-1,067,649 | $-1,053,475 | $-970,336 | $-957,203 | $-16,264 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,194,385 | 1,195,366 | 636,355 | 636,355 | 553,425 |
| Debt Repayment | -309,524 | -307,090 | -4,804 | -2,299 | -465,910 |
| Common Stock Issued | 58,487 | 48,452 | 31,642 | 21,467 | 30,703 |
| Common Stock Repurchased | -42,215 | -29,973 | -23,487 | N/A | -136,484 |
| Other Financing Activity | -190,099 | -185,281 | -181,499 | -157,861 | -5,590 |
| Financing Cash Flow | $711,034 | $721,474 | $458,207 | $497,662 | $-23,856 |
| Exchange Rate Effect | -3,453 | -2,807 | 233 | 188 | 997 |
| Beginning Cash Position | 636,504 | 636,504 | 636,504 | 636,504 | 387,196 |
| End Cash Position | 684,042 | 575,040 | 268,255 | 245,874 | 636,504 |
| Net Cash Flow | $47,538 | $-61,464 | $-368,249 | $-390,630 | $249,308 |
| Free Cash Flow | |||||
| Operating Cash Flow | 407,606 | 273,344 | 143,647 | 68,723 | 288,431 |
| Capital Expenditure | -36,347 | -22,799 | -14,660 | -3,527 | -9,976 |
| Free Cash Flow | 371,259 | 250,545 | 128,987 | 65,196 | 278,455 |